Variant report

Variant	rs10184723
Chromosome Location	chr2:36926342-36926343
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-FEZ2-4	chr2:36926267-36926537	expReg_chr2_2328_-

Extended variants
information (count: 12 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:4)

rs_ID	r²[population]
rs10176102	0.84[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs10178910	0.84[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs10179067	0.84[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs9973672	1.00[AMR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:8 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1010985	chr2:36707157-36942066	Enhancers Weak transcription Strong transcription Genic enhancers Flanking Active TSS Active TSS ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	12 gene(s)	inside rSNPs	diseases
2	nsv535642	chr2:36707157-36942066	Genic enhancers Enhancers Weak transcription Active TSS Strong transcription Flanking Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	12 gene(s)	inside rSNPs	diseases
3	nsv1007757	chr2:36838387-37011384	Weak transcription Enhancers Active TSS Flanking Active TSS ZNF genes & repeats Bivalent Enhancer Strong transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA	5 gene(s)	inside rSNPs	diseases
4	nsv535643	chr2:36838387-37011384	Enhancers Active TSS Flanking Active TSS Weak transcription ZNF genes & repeats Bivalent Enhancer Strong transcription Bivalent/Poised TSS Genic enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA	5 gene(s)	inside rSNPs	diseases
5	nsv1004483	chr2:36875235-37356812	Enhancers Weak transcription Strong transcription Flanking Active TSS Active TSS Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	23 gene(s)	inside rSNPs	diseases
6	nsv535644	chr2:36875235-37356812	Weak transcription Strong transcription Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Active TSS ZNF genes & repeats Genic enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	23 gene(s)	inside rSNPs	diseases
7	nsv873878	chr2:36908661-36942266	Flanking Active TSS Enhancers Weak transcription Genic enhancers Active TSS ZNF genes & repeats Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA	1 gene(s)	inside rSNPs	diseases
8	esv1794298	chr2:36924040-36929933	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region lncRNA	n/a	inside rSNPs	diseases

No data

Chromatin state (count:36 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:36924600-36927200	Enhancers	Primary monocytes fromperipheralblood	blood
2	chr2:36924600-36927200	Enhancers	Primary neutrophils fromperipheralblood	blood
3	chr2:36924600-36927200	Enhancers	Monocytes-CD14+_RO01746	blood
4	chr2:36924800-36928400	Weak transcription	iPS-15b Cell Line	embryonic stem cell
5	chr2:36924800-36928800	Weak transcription	NHLF	lung
6	chr2:36925000-36928000	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
7	chr2:36925000-36928400	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
8	chr2:36925000-36928400	Weak transcription	HUES48 Cell Line	embryonic stem cell
9	chr2:36925000-36928400	Weak transcription	HUES64 Cell Line	embryonic stem cell
10	chr2:36925200-36926800	Enhancers	Hela-S3	cervix
11	chr2:36925200-36927600	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
12	chr2:36925200-36927600	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
13	chr2:36925200-36927800	Weak transcription	HMEC	breast
14	chr2:36925200-36928200	Weak transcription	HUES6 Cell Line	embryonic stem cell
15	chr2:36925200-36928400	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
16	chr2:36925200-36928400	Weak transcription	Fetal Lung	lung
17	chr2:36925200-36928400	Weak transcription	NH-A	brain
18	chr2:36925200-36930600	Weak transcription	A549	lung
19	chr2:36925200-36931400	Weak transcription	HSMMtube	muscle
20	chr2:36925600-36927400	Weak transcription	NHEK	skin
21	chr2:36925600-36928200	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
22	chr2:36925600-36928400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
23	chr2:36925600-36928400	Weak transcription	HUVEC	blood vessel
24	chr2:36925600-36932600	Weak transcription	Right Atrium	heart
25	chr2:36925800-36926600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
26	chr2:36925800-36926600	Enhancers	NHDF-Ad	bronchial
27	chr2:36925800-36927000	Enhancers	Adipose Nuclei	Adipose
28	chr2:36925800-36929000	Weak transcription	Ovary	ovary
29	chr2:36925800-36931000	Enhancers	Breast Myoepithelial Primary Cells	Breast
30	chr2:36925800-36931400	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
31	chr2:36925800-36931600	Weak transcription	Osteobl	bone
32	chr2:36926200-36926400	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
33	chr2:36926200-36926400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
34	chr2:36926200-36926400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
35	chr2:36926200-36926400	Enhancers	Esophagus	oesophagus
36	chr2:36926200-36926600	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links